Assessing the efficacy of Siddha medicines given for Lumbar Spondylosis patients

Assessing the perceived effectiveness of Siddha medicines given for Lumbar Spondylosis patients attending Special OPD at AAGHIM- A CROSS SECTIONAL STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2021/12/038558

Enrollment

100

Registered

2021-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patients who will attend the Mullanthandu Vaatham(Lumbar spondylosis) special OPD at AAGHIM,Chennai. Patients those who are taking special medicines for a mandalam(48 days) and above.

Exclusion criteria

Exclusion criteria: Patients who are new to Special OPD Patients who are failed to followup regularly. Patients who are not willing for this study.

Design outcomes

Primary

Measure	Time frame
The current study will assess the efficacy of Siddha medicines given for LUMBAR SPONDYLOSIS patients attending Out Patient Department at Arignar Anna Government Hospital of Indian Medicine, Chennai. Timepoint: 3months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Anbu N

Government Siddha medical college

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026